巴克莱维持对10x Genomics (TXG) 的超配评级 - 纳斯达克
Barclays Maintains 10x Genomics (TXG) Overweight Recommendation - Nasdaq
生物技术与制药领域的最新动态
Barclays Maintains 10x Genomics (TXG) Overweight Recommendation - Nasdaq
JP Morgan Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq
Why 10x Genomics (TXG) Stock Is Trading Up Today - Yahoo Finance
10X Genomics Tops Q3 Estimates And Cuts Losses - Finimize
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Markets Financial Content
10x Genomics Reports Third Quarter 2025 Financial Results - Barchart.com
10x Genomics Reports Third Quarter 2025 Financial Results - Eastern Progress
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - Nasdaq
10X Genomics earnings beat by $0.07, revenue topped estimates - Investing.com
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics - Nasdaq
10x Genomics (NASDAQ: TXG) guides fourth‑quarter revenue to $154–$158M after results - Stock Titan
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Yahoo Finance
10x Genomics Reports Third Quarter 2025 Financial Results - PR Newswire
10x Genomics scales single-cell analysis platform amid growing market demand - R&D World
10x Genomics Earnings: What To Look For From TXG - Markets Financial Content
10x Genomics Earnings: What To Look For From TXG - Yahoo Finance
10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
10x Genomics (NASDAQ: TXG) launches Chromium Flex enabling 384-sample plate multiplexing - Stock Titan